| Application no. and date | 13779365.9 (espacenet) (Federated) (European Patent Register), 20130812 | | Patent/reg. no. and date | DK/EP 2885007, 20181010 | | Publication date | 20150624 | | Priority no. and date | US 201261684043 P, 20120816 | | EP pub. no. and date |
EP 2885007 20150624 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | P81803578DK00E | | Inventor | KIM, Jin-Hwan, 44 Somerset Drive
Suffern, New York 10901, US,
GU, Jianxin, 267 Voorhis Avenue
River Edge, New Jersey 07661, US,
PRASAD, A. Krishna, 105 Worsham Drive
Chapel Hill, North Carolina 27516, US,
YANG, Yu-ying, 154 Pepper Ridge Road
Unit 11
Stamford, Connecticut 06905, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 47/64 (2017.01) , A61P 31/04 (2006.01) | | Title | Fremgangsmåder til glycokonjugering og sammensætninger | | Int. application no. | IB2013056597 | | Int. publication no. | WO2014027302 | | Related patent (certificate) | CA 2022 00034 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
